CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
CALM Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05087095
NCT05087095N/ACompleted
CompareCT.gov

Managing Distress in Malignant Brain Cancer

Virginia Commonwealth University·interventional·Posted Oct 21, 2021·Updated Apr 9, 2025

In Brief

A clinical study evaluating CALM Intervention for Cancer Metastatic to Brain and Brain Metastases, Adult. Completed, enrolled 13 participants across 1 site.

Detailed Summary

To identify potential adaptations of the managing cancer and living meaningfully (CALM) intervention that will be required for service members, Veterans, their beneficiaries, and civilian cancer metastasis to the brain (bMET) populations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer Metastatic to Brain, Brain Metastases, Adult
CountriesUnited States
CollaboratorsUnited States Department of Defense

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 21, 2021
Enrollment StartMar 23, 2022
Primary CompletionNov 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.7 years ago

Interventions

CALM Interventionbehavioral

The CALM intervention includes 6 individual therapy sessions, each approximately 45-60 minutes in length, delivered over 3 months. Participants will be asked to complete self-report surveys of behavioral and psychological variables surveys at the following timepoints: * Within one week before initiating the CALM intervention therapy * Within one week after its completion, * 3 months after the CALM intervention is complete * After each intervention session, participants will complete a brief post-session survey to assess acceptability of CALM session components